Suchergebnisse - "Polin, Lisa"

PubPharm (34)

1

Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones

enthalten in: Investigational new drugs | 2006

von Marasanapalle, V. | Li, X. | Polin, L. | +1

2

Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones

enthalten in: Investigational new drugs | 2006

von Marasanapalle, V. | Li, X. | Polin, L. | +1

3

Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones

enthalten in: Investigational new drugs | 2006

von Marasanapalle, V. | Li, X. | Polin, L. | +1

4

Cryptophycins-309, 249 and other cryptophycin analogs : preclinical efficacy studies with mouse and human tumors

enthalten in: Investigational new drugs | 2005

von Liang, J. | Moore, R. | Moher, E. | +17

5

Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169

enthalten in: Investigational new drugs | 2003

von Corbett, T. | White, K. | Polin, L. | +4

6

Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169

enthalten in: Investigational new drugs | 2003

von Corbett, T. | White, K. | Polin, L. | +4

7

Preclinical efficacy evaluations of XK-469 : dose schedule, route and cross-resistance behavior in tumor bearing mice

enthalten in: Investigational new drugs | 2002

von Polin, L. | White, K. | Kushner, J. | +9

8

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30

enthalten in: Investigational new drugs | 2002

von Poondru, S. | Parchment, R. | Purohit, V. | +6

9

Lack of in Vitro – in Vivo Correlation of a Novel Investigational Anticancer Agent, SH 30

enthalten in: Investigational new drugs | 2002

von Poondru, S. | Parchment, R. | Purohit, V. | +6

10

Preclinical Efficacy Evaluations of XK-469: Dose Schedule, Route and Cross-Resistance Behavior in Tumor Bearing Mice

enthalten in: Investigational new drugs | 2002

von Polin, L. | White, K. | Kushner, J. | +9